Midodrine Hydrochloride NDC 55154-5696

NDC codes

FDA NDC Directory

Product NDC (as listed)55154-5696Labeler and product segments. Claims need a package NDC.

Product NDC at billing width55154-5696Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
55154-5696-0	55154569600	10 BLISTER PACK in 1 BAG (55154-5696-0) / 1 TABLET in 1 BLISTER PACKMarketed from Sep 11, 2006

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Midodrine Hydrochloride
Generic name (nonproprietary): midodrine hydrochloride
Active ingredients: Midodrine hydrochloride — 5 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Cardinal Health 107, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 076577
Marketing start: Sep 11, 2006
Listing expires: Dec 31, 2026
Other FDA classes: Adrenergic alpha-Agonists (Mechanism)
Identifiers: Product ID 55154-5696_84566444-a9a9-4903-979a-112d831e324eSPL ID 84566444-a9a9-4903-979a-112d831e324eSPL set ID 66bccee4-b466-4fe9-89d6-8c9eaaa92413RxCUI 993470UNII 59JV96YTXVUPC 0055154569606
Pharmacologic class: alpha-Adrenergic Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N455154569600 followed by a unit qualifier and the quantity

Package 55154-5696-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 13, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Midodrine hydrochloride tablets are indicated for the treatment of symptomatic orthostatic hypotension (OH). Because midodrine hydrochloride tablets can cause marked elevation of supine blood pressure (BP > 200 mmHg systolic), it should be used in patients whose lives are considerably impaired despite standard clinical care, including non-pharmacologic treatment (such as support stockings), fluid expansion, and lifestyle alterations. The indication is based on midodrine hydrochloride tablets' effect on increases in 1-minute standing systolic blood pressure, a surrogate marker considered likely to correspond to a clinical benefit. At present, however, clinical benefits o…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 076577

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 076577
Product	Strength	Form · route	Labeler	Product NDC
Midodrine Hydrochloride	Midodrine hydrochloride 5 mg/1	TabletOral	Mylan Institutional Inc.	51079-453
Midodrine Hydrochloride	Midodrine hydrochloride 2.5 mg/1	TabletOral	Mylan Pharmaceuticals Inc.	0378-1901
Midodrine Hydrochloride	Midodrine hydrochloride 5 mg/1	TabletOral	Mylan Pharmaceuticals Inc.	0378-1902
Midodrine Hydrochloride	Midodrine hydrochloride 10 mg/1	TabletOral	Mylan Pharmaceuticals Inc.	0378-1903
Midodrine Hydrochloride	Midodrine hydrochloride 5 mg/1	TabletOral	Safecor Health LLC	48433-075